Shanghai Cancer Centre
Shanghai Cancer Centre
Explore linked clinical trials.4 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| EVM16 Injection as a Single and Combination With Tislelizumab in Solid Tumors | Advanced or Recurrent Solid Tumors | Recruiting | Phase 1 | 2026-06-22 | NCT06541639 | |
| T Cell Lymphoma -Stratified Therapy After Response to First-line Treatment-NR | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, T-cell non-Hodgkin lymphoma, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, mature T-cell and NK-cell non-Hodgkin lymphoma, neoplasm | Recruiting | Not stated | 2026-03-13 | NCT07470996 | |
| Omitting Nasogastric Tube Decompression in Minimally Invasive Pancreaticoduodenectomy | Minimally Invasive Surgical Procedures; Nasogastric Tube Decompression; Pancreaticoduodenectomy | Not yet recruiting | Phase 2 | 2026-03-12 | NCT07370116 | |
| A Phase I First-in-Human Open-Label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Anti-Tumor Activity of SWA1211 Tablets in Subjects With Advanced Solid Tumors | Solid Tumor Malignancies | Recruiting | Phase 1 | 2026-01-23 | NCT07363967 |